The Brookings Institution has released a $250M plan for a postmarket medical device tracking system, under an arrangement with the FDA. According to FedScoop.com, “under the plan, the National Medical Device Postmarket Surveillance System would use the ‘experiences of patients to inform decisions about medical device safety, effectiveness, and quality in order to promote the public health.'” To learn more about this initiative, please visit: http://fedscoop.com/brookings-fda-release-250m-plan-for-medical-device-surveillance